Why Pot Is Still a LONG Way from Becoming Federally Legal

August 13, 2019 Cannabis , Medicine , Regulation

It’s the end of summer in the year 2020.

The United States of America is yet again divided amongst the political playoffs. Leftists, Rightists, Centrists, and anarchists alike, all flood the social media pages with their own plagiarized opinions and outcries. People keep their eyes glued to the news stations and allow all notifications on their phone’s news app. Another scandal comes to light. This one, shockingly, seems worse than the last dozen. Your mother calls and asks if you are registered to vote… 

Somehow you survive through all the maelstroms of media and scandals.

It’s now November. You’ve unfriended a few people on your socials as well as shared your views to anyone who would listen. But now, finally, it’s time to go to the polls and make Mom proud. After standing in line in a crowd that only holds feelings of desperation and insecurity, it’s your turn to make your voice heard. You enter your booth and ready your pen only to find one thing missing. There is STILL no bill which will legalize marijuana on a federal level. 

A silent tear escapes your right eye.

In 2019, 33 states have already legalized the usage of marijuana to some capacity. 11 of those states, as well as the District of Columbia, have established laws allowing citizens to partake in using marijuana recreationally, legally. That is, legally by state (or district) law. The federal government agencies; the Drug Enforcement Administration (DEA) and the Food and Drug Administration (FDA) still view marijuana as a Schedule I drug. By the DEA’s definition: “Schedule I drugs, substances, or chemicals are defined as drugs with no currently accepted medical use and a high potential for abuse.” However, it should be noted that the FDA has already approved two cannabinoid products, which are available to select patients through prescription. Marinol (dronabinol), which came to market in 1985, is indicated for the treatment of nausea and vomiting associated with cancer chemotherapy. Cesamet (nabilone), which was approved by the FDA in 2006, for the treatment of nausea and vomiting associated with cancer chemotherapy in patients who have failed to respond adequately to conventional antiemetic treatments.

Despite these legal versions of THC and CBD already on the market, the marijuana plant is still seen by the federal government as harmful, abusive, and medically useless. With all the investigations, rumors, resignations, and allegations we have yet to tune in for, it is highly unlikely our dear plant will be brought into the center of attention during these upcoming elections. More states may legalize marijuana themselves but Uncle Sam, like us, will most likely be distracted by the latest news story. Hang in there friends. Federal legalization is still coming, but it won’t be in 2020.

-Dr. KEA 

Interested in discussing more? Contact us we’d love to hear your thoughts!

Comments

If you have a question, suggestion or a link share below!

Your email address will not be published. Required fields are marked *